Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Culture Dish Helps Human Embryonic Stem Cell Research

By LabMedica International staff writers
Posted on 08 Jul 2010
A new synthetic Petri dish coating could overcome a major hurdle to the advancement of human embryonic stem cell research.

Under current regulations, current stem cell lines have limitations in yielding human therapies because the cells have been grown on animal-based substances that do not behave in expected ways. More...
"These nondefined, animal-based components create issues with the FDA [U.S. Food and Drug Administration] and hinder clinical applications,” said Dr. Joerg Lahann, associate professor of chemical engineering at the University of Michigan (U-M; Ann Arbor, USA).

Dr. Lahann and Dr. Gary Smith, an associate professor in obstetrics and gynecology in the U-M Health System, and their coworkers constructed a new stem cell growth matrix that is completely synthetic and does not contaminate the stem cells with foreign substances that could interfere with their normal function. An article on the research was published online, on June 2010 in the journal Nature Biotechnology.

Today's most typically used matrices are mouse embryonic fibroblast cells and Matrigel, which is made from mouse tumors. "The problem is that the mouse-derived cells have batch-to-batch variability, and they secrete factors that nobody really understands. Stem cells are very sensitive to their environment,” Dr. Lahann said.

The unknown factors hamper researchers' attempts to pinpoint how and under what conditions stem cells differentiate--questions paramount to the development of future stem cell therapies.

The team evaluated six different polymer coatings and found that a water-soluble gel with the acronym PMEDSAH performed well when attached to the Petri dish even after 25 rounds of harvesting stem cells to grow new colonies. "We have designed a fully synthetic, fully chemically defined hydrogel that has long-term stability and no batch-to-batch variability,” Dr. Smith noted. "Moreover, we have established that it can be used for long-term growth of human embryonic stem cells while maintaining all of their known normal functions. These include normal genetic makeup, lack of spontaneous differentiation, and maintenance of pluripotency, which means they can still become any cell type of the human body. This is a perfect example of an interdisciplinary collaboration leading to information gained and future discovery of cures and improvements of human health.”

Related Links:

University of Michigan



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.